Healthcare's war on waste
⚕️ Can hospitals cut emissions by 44%? The surprising case for reusing "single-use" medical devices
❓ Question:
How can remanufacturing single-use medical devices help reduce healthcare waste, improve supply chain resilience and lower emissions without compromising patient safety?
✅ Answer:
According to Daniel Vukelich, president of the Association of Medical Device Reprocessors (AMDR), healthcare's reliance on single-use medical devices has created significant waste, emissions and supply chain vulnerabilities. While many devices are labelled for single use, remanufacturing companies can clean, validate, test and sterilise eligible products so they can be safely used again.
Vukelich argues that remanufacturing offers a practical circular economy solution that reduces costs, cuts healthcare emissions, improves supply chain resilience and recovers valuable materials that would otherwise be discarded. With healthcare accounting for around 5% of global emissions and increasing pressure on global supply chains following COVID-19 and geopolitical disruptions, he believes circular healthcare models will become increasingly important for hospitals, policymakers and investors.
🌟 Healthcare is a major contributor to global emissions
If healthcare were a country, it would rank among the world's largest emitters. Healthcare-related activities account for approximately 5% of global emissions, making decarbonisation a growing priority for the sector.
🌟 Circular healthcare can reduce dependence on fragile supply chains
COVID-19 exposed vulnerabilities in global medical supply chains. Remanufacturing enables hospitals to extend the life of existing devices and reduces dependence on imported products and raw materials.
🌟 Valuable materials can be recovered and reused
Many medical devices contain microchips, rare earth metals, gold and other valuable materials. Remanufacturing helps recover these resources rather than sending them to landfill or incineration.
🌟 Hospitals can significantly reduce procurement costs
The remanufacturing industry has delivered substantial savings to healthcare systems by allowing eligible devices to be safely reused rather than constantly replaced with new products.
🌟 Emissions can be reduced by remanufacturing devices closer to home
Lifecycle assessments suggest remanufacturing can reduce emissions by around 44% compared with manufacturing entirely new devices because fewer raw materials need to be extracted, processed and transported.
🌟 Scope 3 emissions present a major opportunity
Around 70% of hospital emissions originate from supply chains rather than hospital operations. Addressing procurement and medical device lifecycles could have a larger impact than operational changes alone.
🌟 Australia is moving closer to developing a remanufacturing sector
Several companies have announced plans to invest in Australian remanufacturing capability, while regulators continue to assess the appropriate framework for medical device reuse and remanufacturing.
🌟 Circular business models could become a competitive advantage
Vukelich believes medical technology companies that extend product lifecycles and offer circular solutions are likely to be better positioned as healthcare systems focus more on sustainability and resilience.
🚩 Regulatory frameworks are still evolving
Australia is still developing the regulatory settings required to support a larger remanufacturing industry while maintaining patient safety and clinical confidence.
🚩 Existing healthcare procurement models favour single-use products
Many purchasing decisions remain focused on upfront unit costs rather than whole-of-life costs, supply chain security and environmental impacts.
🚩 Established business models may resist change
Manufacturers that rely on selling new devices may be reluctant to adopt circular approaches that extend product lifespans and reduce replacement rates.
🚩 Clinical participation is critical
Remanufacturing programs depend on hospitals consistently collecting and separating eligible devices for reuse. Without clinician engagement, significant benefits can be lost.
⚠️ Healthcare's environmental footprint is larger than many realise
Despite healthcare's mission to improve health outcomes, the sector remains a significant source of waste and carbon emissions.
⚠️ Supply chain disruptions are becoming a strategic risk
Pandemics, trade tensions, tariffs and geopolitical conflicts continue to create uncertainty in healthcare supply chains, increasing costs and reducing resilience.
⚠️ Sustainability alone will not drive change
Vukelich argues that adoption must be supported by strong business and financial cases, not environmental benefits alone.
⚠️ Procurement practices may determine the pace of adoption
Unless healthcare buyers actively reward sustainable and circular solutions, progress towards circular healthcare models may remain slow.
💡 Why it matters:
Healthcare is increasingly being viewed through both a sustainability and supply chain lens. As hospitals seek to reduce costs, improve resilience and cut emissions, circular approaches such as medical device remanufacturing are attracting greater attention globally. For investors, healthcare providers and policymakers, the transition from a linear "take-make-waste" model to a circular healthcare system could create new commercial opportunities while helping address waste, carbon emissions and resource constraints.
🎙️ Sources:
Daniel Vukelich, president, Association of Medical Device Reprocessors (AMDR)
Michelle Baltazar, host, The Greener Way
⏱️ Timestamps:
00:00 – Why healthcare emissions matter
01:25 – What circular healthcare means
01:49 – The rise of single-use medical devices
02:35 – What remanufacturing and reprocessing involve
03:34 – Common misconceptions about reuse and recycling
04:15 – How COVID changed the conversation
05:00 – Types of devices that can be remanufactured
06:12 – Cost savings and supply chain resilience
07:33 – Australia's emerging remanufacturing opportunity
08:40 – The emissions benefits of remanufacturing
09:37 – Healthcare's carbon footprint and Scope 3 emissions
10:26 – Barriers and industry resistance
11:49 – Regulation, procurement and policy priorities
12:49 – The future of circular healthcare
13:36 – Potential benefits for developing countries
14:09 – Sustainability, business and healthcare waste reduction
🌿 We record on Gadigal Land and pay our respects to the traditional custodians of Country and elders past and present.
This podcast uses the following third-party services for analysis:
OP3 - https://op3.dev/privacy
